RISS STAGE II PLASMA CELL MYELOMA
Clinical trials for RISS STAGE II PLASMA CELL MYELOMA explained in plain language.
Never miss a new study
Get alerted when new RISS STAGE II PLASMA CELL MYELOMA trials appear
Sign up with your email to follow new studies for RISS STAGE II PLASMA CELL MYELOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Major cancer trial aims to boost survival for blood cancer patients
Disease control Recruiting nowThis large, late-stage trial is comparing two drug combinations for people newly diagnosed with a type of blood cancer called multiple myeloma. It will test if adding a fourth drug (bortezomib) to a standard three-drug regimen helps patients live longer and keeps the cancer from …
Matched conditions: RISS STAGE II PLASMA CELL MYELOMA
Phase: PHASE3 • Sponsor: ECOG-ACRIN Cancer Research Group • Aim: Disease control
Last updated Mar 23, 2026 15:16 UTC
-
One blood test for many cancers? study aims to find out
Diagnosis Recruiting nowThis study aims to collect blood and tissue samples to help develop a single blood test that can detect many different cancers early. Researchers will enroll 2,000 people, including those with cancer and those without, to create a reference set for testing. The goal is to validat…
Matched conditions: RISS STAGE II PLASMA CELL MYELOMA
Sponsor: Alliance for Clinical Trials in Oncology • Aim: Diagnosis
Last updated Mar 30, 2026 14:28 UTC